OMER FY 2011 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$826M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+114.9% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$27M-605.9% margin

Net Income

-$29M-631.0% margin

EPS (Diluted)

$-1.29

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$27M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$27M

Total Liabilities

$33M

Stockholders' Equity

-$6M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$2M	+114.9%
Gross Profit	$5M	$2M	+114.9%
Operating Income	-$27M	-$30M	+9.0%
Net Income	-$29M	-$29M	+2.4%